Clinical Trial Update: A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults [Phase 1]

View source ↗

Summary

A Phase I study of the quadrivalent HPV vaccine (types 6, 11, 16, 18) in HIV-infected and HIV-negative pre-adolescents to young adults has been terminated. Resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Genital Warts
• Human Papillomavirus Infection

Drugs mentioned

• Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Human Immunodeficiency Virus, Human Papillomavirus- 6, 11, 16, 18 | Phase 1 | Status: TERMINATED | Results posted: 2024-11-20